0000939767-24-000126.txt : 20240809 0000939767-24-000126.hdr.sgml : 20240809 20240809193219 ACCESSION NUMBER: 0000939767-24-000126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240807 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aftab Dana CENTRAL INDEX KEY: 0001959132 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 241194381 MAIL ADDRESS: STREET 1: EXELIXIS, INC. STREET 2: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0103 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wk-form4_1723246333.xml FORM 4 X0508 4 2024-08-07 0 0000939767 EXELIXIS, INC. EXEL 0001959132 Aftab Dana C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 CSO/EVP Disc & Trans Research 1 Common Stock 2024-08-07 4 M 0 95000 24.41 A 615990 D Common Stock 2024-08-07 4 S 0 95000 25 D 520990 D Common Stock 5835 I By 401(k) Option (right to buy) 24.41 2024-08-07 4 M 0 95000 0 D 2018-10-03 2024-10-02 Common Stock 95000 0 D Includes 288,932 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 7, 2024. The option, representing the right to purchase a total of 95,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021. /s/ Nina Ayer, Attorney in Fact 2024-08-09